Wai Yuen Tong Medicine Holdings (HKSE:00897) Accounts Payable & Accrued Expense : HK$432 Mil (As of Sep. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Wai Yuen Tong Medicine Holdings Accounts Payable & Accrued Expense?

Wai Yuen Tong Medicine Holdings's quarterly accounts payable & accrued expense increased from Sep. 2022 (HK$500 Mil) to Mar. 2023 (HK$866 Mil) but then declined from Mar. 2023 (HK$866 Mil) to Sep. 2023 (HK$432 Mil).

Wai Yuen Tong Medicine Holdings's annual accounts payable & accrued expense declined from Mar. 2021 (HK$582 Mil) to Mar. 2022 (HK$540 Mil) but then increased from Mar. 2022 (HK$540 Mil) to Mar. 2023 (HK$866 Mil).

Wai Yuen Tong Medicine Holdings Accounts Payable & Accrued Expense Historical Data

The historical data trend for Wai Yuen Tong Medicine Holdings's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wai Yuen Tong Medicine Holdings Accounts Payable & Accrued Expense Chart

Wai Yuen Tong Medicine Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

66.37

349.38

581.90

539.88

865.73

Wai Yuen Tong Medicine Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															576.48	539.88	499.65	865.73	432.21

Wai Yuen Tong Medicine Holdings Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wai Yuen Tong Medicine Holdings Ltd (HKSE:00897) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

39 Wang Kwong Road, Suite 3101, 31st Floor, Skyline Tower, Kowloon Bay, Kowloon, Hong Kong, HKG

Website

https://www.wyth.net

Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties in the agricultural produce market. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.

Executives

Wang On Group Limited	2501 Other
Tang Ching Ho	2501 Other
Yau Yuk Yin	2202 Interest of your spouse

Wai Yuen Tong Medicine Holdings (HKSE:00897) Headlines

No Headlines